These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1266 related articles for article (PubMed ID: 3417559)
1. BMY-28438 (3,7-dihydroxytropolone), a new antitumor antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity. Sugawara K; Ohbayashi M; Shimizu K; Hatori M; Kamei H; Konishi M; Oki T; Kawaguchi H J Antibiot (Tokyo); 1988 Jul; 41(7):862-8. PubMed ID: 3417559 [TBL] [Abstract][Full Text] [Related]
2. BMY-28438 (3,7-dihydroxytropolone), a new antitumor antibiotic active against B16 melanoma. II. Taxonomy of producing organism. Tomita K; Hoshino Y; Nakakita Y; Umezawa S; Miyaki T; Oki T; Kawaguchi H J Antibiot (Tokyo); 1989 Feb; 42(2):317-21. PubMed ID: 2925523 [No Abstract] [Full Text] [Related]
3. Chicamycin, a new antitumor antibiotic. I. Production, isolation and properties. Konishi M; Hatori M; Tomita K; Sugawara M; Ikeda C; Nishiyama Y; Imanishi H; Miyaki T; Kawaguchi H J Antibiot (Tokyo); 1984 Mar; 37(3):191-9. PubMed ID: 6547127 [TBL] [Abstract][Full Text] [Related]
4. Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity. Sugawara K; Hatori M; Nishiyama Y; Tomita K; Kamei H; Konishi M; Oki T J Antibiot (Tokyo); 1990 Jan; 43(1):8-18. PubMed ID: 2106503 [TBL] [Abstract][Full Text] [Related]
5. Prothracarcin, a novel antitumor antibiotic. Shimizu K; Kawamoto I; Tomita F; Morimoto M; Fujimoto K J Antibiot (Tokyo); 1982 Aug; 35(8):972-8. PubMed ID: 7142014 [TBL] [Abstract][Full Text] [Related]
6. UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties. Ueki M; Ueno K; Miyadoh S; Abe K; Shibata K; Taniguchi M; Oi S J Antibiot (Tokyo); 1993 Jul; 46(7):1089-94. PubMed ID: 8360104 [TBL] [Abstract][Full Text] [Related]
12. CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity. Martin DG; Biles C; Gerpheide SA; Hanka LJ; Krueger WC; McGovren JP; Mizsak SA; Neil GL; Stewart JC; Visser J J Antibiot (Tokyo); 1981 Sep; 34(9):1119-25. PubMed ID: 7328053 [No Abstract] [Full Text] [Related]
13. Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity. Konishi M; Sugawara K; Kofu F; Nishiyama Y; Tomita K; Miyaki T; Kawaguchi H J Antibiot (Tokyo); 1986 Jun; 39(6):784-91. PubMed ID: 3733527 [TBL] [Abstract][Full Text] [Related]
14. [Isolation and study of a new antitumor antibiotic produced by a Str. coerulescens 1072 culture]. Frolova VI; Kuzovkov AD; Rozynov BV; Sheichenko VI; Taĭg MM Antibiotiki; 1982 Aug; 27(8):563-9. PubMed ID: 7125613 [No Abstract] [Full Text] [Related]
15. Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent. Schurig JE; Rose WC; Kamei H; Nishiyama Y; Bradner WT; Stringfellow DA Invest New Drugs; 1990 Feb; 8(1):7-15. PubMed ID: 2345072 [TBL] [Abstract][Full Text] [Related]
16. BBM-928, a new antitumor antibiotic complex. I. Production, isolation, characterization and antitumor activity. Ohkuma H; Sakai F; Nishiyama Y; Ohbayashi M; Imanishi H; Konishi M; Miyaki T; Koshiyama H; Kawaguchi H J Antibiot (Tokyo); 1980 Oct; 33(10):1087-97. PubMed ID: 7451357 [TBL] [Abstract][Full Text] [Related]
17. Chrolactomycin, a novel antitumor antibiotic produced by Streptomyces sp. Nakai R; Kakita S; Asai A; Chiba S; Akinaga S; Mizukami T; Yamashita Y J Antibiot (Tokyo); 2001 Oct; 54(10):836-9. PubMed ID: 11776440 [No Abstract] [Full Text] [Related]